Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 7/2011

01-10-2011 | original paper

Predicting Adherence to Antiretroviral Therapy in HIV-Infected Older Adults: The Moderating Role of Gender

Authors: Joseph A. Bianco, Timothy G. Heckman, Mark Sutton, Rewadee Watakakosol, Travis Lovejoy

Published in: AIDS and Behavior | Issue 7/2011

Login to get access

Abstract

This study characterized rates and correlates of ART adherence in 242 HIV-infected persons 50+ years of age. Hierarchical regressions tested a model in which depression mediated the relationships between social support and avoidance coping with ART adherence. Results indicated low rates of consistent and timely adherence in both men (48%) and women (51%). For men and women alike, social support and avoidance coping predicted depression. Although rates of adherence and predictors of depression did not differ by gender, predictors of adherence did. Avoidance coping, social support and depression predicted ART adherence in older men, but not in older women. Contrary to expectations, depression did not mediate the relationships of coping and social support with ART adherence for either gender. These findings suggest that while HIV-infected older men and women share similar paths toward depression, they diverge in predictors of adherence. Adherence interventions may be more efficacious if they are sensitive to gender differences, although more research is first needed to identify factors related to adherence in HIV-infected older women.
Literature
1.
2.
Grabar S, Weiss L, Costagliola D. HIV infection in older patients in the HAART era. J Antimicrob Chemother. 2006;57(1):4–7.PubMedCrossRef
3.
Emlet CA, Farkas KJ. Correlates of service utilization among midlife and older adults with HIV/AIDS: the role of age in the equation. J Aging Health. 2002;14(3):315–35.PubMedCrossRef
4.
Martin CP, Fain MJ, Klotz SA. The older HIV-positive adult: a critical review of the medical literature. Am J Med. 2008;121(12):1032–7.PubMedCrossRef
5.
Rabkin JG, McElhiney MC, Ferrando SJ. Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence. AIDS. 2004;18(Suppl 1):S43–8.
6.
Skiest DJ, Rubinstien E, Carley N, Gioiella L, Lyons R. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study. Am J Med. 1996;101(6):605–11.PubMedCrossRef
7.
Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP Jr. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167(7):684–91.PubMedCrossRef
8.
Murray MD, Smith FE, Fox J, et al. Structure, functions, and activities of a research support informatics section. J Am Med Inform Assoc. 2003;10(4):389–98.
9.
Shippy RA, Karpiak SE. The aging HIV/AIDS population: fragile social networks. Aging Ment Health. 2005;9(3):246–54.PubMedCrossRef
10.
Pratt G, Gascoyne K, Cunningham K, Tunbridge A. Human immunodeficiency virus (HIV) in older people. Age Ageing. 2010;39(3):289–94.PubMedCrossRef
11.
Zablotsky D, Kennedy M. Risk factors and HIV transmission to midlife and older women: knowledge, options, and the initiation of safer sexual practices. J Acquir Immune Defic Syndr. 2003;33(Suppl 2):S122–30.
12.
Conde DM, Silva ET, Amaral WN, et al. HIV, reproductive aging, and health implications in women: a literature review. Menopause. 2009;16(1):199–213.
13.
Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119–29.
14.
Bangsberg DR. Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: the past, the present, and the future. AIDS Behav. 2006;10(3):249–51.PubMedCrossRef
15.
Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med. 2002;17(10):812–3.PubMedCrossRef
16.
Catz SL, Heckman TG, Kochman A, DiMarco M. Rates and correlates of HIV treatment adherence among late middle-aged and older adults living with HIV disease psychology. Health Med. 2001;6:47–58.
17.
Johnson CJ, Heckman TG, Hansen NB, Kochman A, Sikkema KJ. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care. 2009;21(5):541–51.PubMedCrossRef
18.
Arnstein JH, Li X, Mizuno Y, et al. Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. J Acquir Immune Defic Syndr. 2007;46(S64–71).
19.
Gordillo V, Fekete EM, Platteau T, Antoni MH, Schneiderman N, Nostlinger C. Emotional support and gender in people living with HIV: effects on psychological well-being. J Behav Med. 2009 Jun 19.
20.
Weaver KE, Llabre MM, Duran RE, et al. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol. 2005;24(4):385–92.
21.
Gonzalez JS, Penedo FJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004;23(4):413–8.
22.
Simoni JM, Frick PA, Lockhart D, Liebovitz D. Mediators of social support and antiretroviral adherence among an indigent population in New York city. AIDS Patient Care STDS. 2002;16(9):431–9.PubMedCrossRef
23.
Yesavage J, Brink T, Rose TL, Leirer VO. Development and validation of the geriatric depression screening scale: a preliminary report. J Psychiatry Res. 1983;17:37–49.CrossRef
24.
Turner RJ, Frankel BG, Levin DM. Social support: conceptualization, measurement, and implications for mental health. Res Commun Ment Health. 1983;3:67–111.
25.
Sikkema KJ, Kelly JA, Winett RA, et al. Outcomes of a randomized community-level HIV prevention intervention for women living in 18 low-income housing developments. Am J Public Health. 2000;90(1):57–63.PubMedCrossRef
26.
Folkman S, Lazarus RS. The ways of coping questionnaire. Palo Alto: Consulting Psychologists Press. 1988.
27.
Heckman TG, Anderson ES, Sikkema KJ, Kochman A, Kalichman SC, Anderson T. Emotional distress in nonmetropolitan persons living with HIV disease enrolled in a telephone-delivered, coping improvement group intervention. Health Psychol. 2004;23(1):94–100.PubMedCrossRef
28.
Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the adult aids clinical trials group (AACTG). AIDS Care. 2000;12(3):255–66.
29.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.PubMedCrossRef
30.
Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40(3):879–91.PubMedCrossRef
31.
32.
Mackinnon DP, Lockwood C, Hoffman J, West S, Sheets V. A comparison of mehtods to test mediation and other intervening variable effects. Psychol Methods. 2002;7:83–104.PubMedCrossRef
33.
Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36(4):717–31.PubMedCrossRef
34.
Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19–25.
35.
Richardson J, Barkan S, Cohen M, et al. Experience and covariates of depressive symptoms among a cohort of HIV infected women. Soc Work Health Care. 2001;32(4):93–111.PubMedCrossRef
36.
Sayles JN, Wong MD, Cunningham WE. The inability to take medications openly at home: does it help explain gender disparities in HAART use? J Womens Health (Larchmt). 2006;15(2):173–81.CrossRef
37.
Solomon P, Wilkins S. Participation among women living with HIV: a rehabilitation perspective. AIDS Care. 2008;20(3):292–6.PubMedCrossRef
38.
39.
Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19:1111–7.PubMedCrossRef
40.
41.
Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.
42.
Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among hiv-infected drug users: a meta-analysis. AIDS Behav. 2008.
43.
Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38(4):445–8.
44.
Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.PubMedCrossRef
Metadata
Title
Predicting Adherence to Antiretroviral Therapy in HIV-Infected Older Adults: The Moderating Role of Gender
Authors
Joseph A. Bianco
Timothy G. Heckman
Mark Sutton
Rewadee Watakakosol
Travis Lovejoy
Publication date
01-10-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 7/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9756-2

Other articles of this Issue 7/2011

AIDS and Behavior 7/2011 Go to the issue

Original Paper

Work-related Barriers and Facilitators to Antiretroviral Therapy Adherence in Persons Living with HIV Infection

Original Paper

The Skinny on Sexual Risk: The Effects of BMI on STI Incidence and Risk

Original Paper

The Relative Role of Perceived Partner Risks in Promoting Condom Use in a Three-City Sample of High-Risk, Low-Income Women

Report

Incomplete Use of Condoms: The Importance of Sexual Arousal

Original Paper

Medication Adherence: Tailoring the Analysis to the Data

Commentary

Syringe-Mediated Syndemics
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits